Professor Mohty’s translational research activity is focused on the pathophysiology of graft-vs-host disease and the immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as IMiDs and hypomethylating agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma.
讲座视频:0
论文摘要:1
253
0
0
日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2021-06-19 | 15:15-15:35 | 铂瑞厅3 |
临床转化分会场7 |
讲者 | Allogeneic Stem Cell Transplantation for Refractory Acute Myeloid Leukemia |